Tumor Heterogeneity Makes AML a "Moving Target" for Detection of Residual Disease

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)3-14
JournalCytometry Part B. Clinical Cytometry
Volume86
Issue number1
DOIs
Publication statusPublished - 2014

Cite this

@article{3d22a3f73e2b46c988d9ab5d6a5c8ef5,
title = "Tumor Heterogeneity Makes AML a {"}Moving Target{"} for Detection of Residual Disease",
author = "W. Zeijlemaker and J.W. Gratama and G.J. Schuurhuis",
year = "2014",
doi = "10.1002/cyto.b.21134",
language = "Undefined/Unknown",
volume = "86",
pages = "3--14",
journal = "Cytometry Part B. Clinical Cytometry",
issn = "1552-4949",
publisher = "Wiley-Liss Inc.",
number = "1",

}

Tumor Heterogeneity Makes AML a "Moving Target" for Detection of Residual Disease. / Zeijlemaker, W.; Gratama, J.W.; Schuurhuis, G.J.

In: Cytometry Part B. Clinical Cytometry, Vol. 86, No. 1, 2014, p. 3-14.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Tumor Heterogeneity Makes AML a "Moving Target" for Detection of Residual Disease

AU - Zeijlemaker, W.

AU - Gratama, J.W.

AU - Schuurhuis, G.J.

PY - 2014

Y1 - 2014

U2 - 10.1002/cyto.b.21134

DO - 10.1002/cyto.b.21134

M3 - Article

VL - 86

SP - 3

EP - 14

JO - Cytometry Part B. Clinical Cytometry

JF - Cytometry Part B. Clinical Cytometry

SN - 1552-4949

IS - 1

ER -